nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP3A4—breast cancer	0.2	1	CbGaD
Glipizide—CYP2C9—Anastrozole—breast cancer	0.0503	0.114	CbGbCtD
Glipizide—CYP3A4—Exemestane—breast cancer	0.0386	0.0873	CbGbCtD
Glipizide—CYP2C9—Idarubicin—breast cancer	0.0381	0.0862	CbGbCtD
Glipizide—CYP3A4—Letrozole—breast cancer	0.0328	0.0742	CbGbCtD
Glipizide—CYP3A4—Anastrozole—breast cancer	0.0293	0.0662	CbGbCtD
Glipizide—CYP3A4—Toremifene—breast cancer	0.0268	0.0605	CbGbCtD
Glipizide—CYP3A4—Fulvestrant—breast cancer	0.0249	0.0562	CbGbCtD
Glipizide—CYP3A4—Thiotepa—breast cancer	0.0222	0.0501	CbGbCtD
Glipizide—CYP2C9—Capecitabine—breast cancer	0.0209	0.0472	CbGbCtD
Glipizide—CYP3A4—Ixabepilone—breast cancer	0.0203	0.0459	CbGbCtD
Glipizide—CYP3A4—Lapatinib—breast cancer	0.0195	0.0441	CbGbCtD
Glipizide—CYP2C9—Tamoxifen—breast cancer	0.0168	0.038	CbGbCtD
Glipizide—CYP3A4—Raloxifene—breast cancer	0.0148	0.0335	CbGbCtD
Glipizide—CYP2C9—Paclitaxel—breast cancer	0.0131	0.0296	CbGbCtD
Glipizide—CYP2C9—Fluorouracil—breast cancer	0.0124	0.028	CbGbCtD
Glipizide—CYP3A4—Vinorelbine—breast cancer	0.0108	0.0245	CbGbCtD
Glipizide—CYP3A4—Tamoxifen—breast cancer	0.00977	0.0221	CbGbCtD
Glipizide—CYP3A4—Mitoxantrone—breast cancer	0.00953	0.0216	CbGbCtD
Glipizide—CYP3A4—Paclitaxel—breast cancer	0.00761	0.0172	CbGbCtD
Glipizide—CYP3A4—Irinotecan—breast cancer	0.0075	0.017	CbGbCtD
Glipizide—CYP3A4—Vinblastine—breast cancer	0.00667	0.0151	CbGbCtD
Glipizide—CYP3A4—Docetaxel—breast cancer	0.0055	0.0124	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—breast cancer	0.0041	0.00927	CbGbCtD
Glipizide—PPARG—Topotecan—Irinotecan—breast cancer	0.003	1	CbGdCrCtD
Glipizide—KCNJ11—mammary gland—breast cancer	0.00275	0.0914	CbGeAlD
Glipizide—ABCC8—mammary gland—breast cancer	0.00253	0.0842	CbGeAlD
Glipizide—PPARG—mammary gland—breast cancer	0.00193	0.0642	CbGeAlD
Glipizide—PPARG—nipple—breast cancer	0.0016	0.0531	CbGeAlD
Glipizide—PPARG—embryo—breast cancer	0.00132	0.0438	CbGeAlD
Glipizide—ABCC8—endometrium—breast cancer	0.00127	0.042	CbGeAlD
Glipizide—ABCC8—pituitary gland—breast cancer	0.00115	0.038	CbGeAlD
Glipizide—KCNJ11—female reproductive system—breast cancer	0.00114	0.0378	CbGeAlD
Glipizide—CYP2C9—mammary gland—breast cancer	0.00113	0.0376	CbGeAlD
Glipizide—KCNJ11—adrenal gland—breast cancer	0.00111	0.0369	CbGeAlD
Glipizide—Glyburide—CPT1A—breast cancer	0.0011	0.299	CrCbGaD
Glipizide—PPARG—epithelium—breast cancer	0.00108	0.0358	CbGeAlD
Glipizide—KCNJ11—female gonad—breast cancer	0.00104	0.0344	CbGeAlD
Glipizide—PPARG—skin of body—breast cancer	0.00102	0.034	CbGeAlD
Glipizide—ABCC8—adrenal gland—breast cancer	0.00102	0.034	CbGeAlD
Glipizide—KCNJ11—endocrine gland—breast cancer	0.000963	0.032	CbGeAlD
Glipizide—PPARG—uterus—breast cancer	0.00089	0.0296	CbGeAlD
Glipizide—ABCC8—endocrine gland—breast cancer	0.000887	0.0295	CbGeAlD
Glipizide—PPARG—adipose tissue—breast cancer	0.000871	0.0289	CbGeAlD
Glipizide—PPARG—female reproductive system—breast cancer	0.0008	0.0266	CbGeAlD
Glipizide—Gliclazide—VEGFA—breast cancer	0.000791	0.215	CrCbGaD
Glipizide—PPARG—adrenal gland—breast cancer	0.000781	0.0259	CbGeAlD
Glipizide—PPARG—bone marrow—breast cancer	0.000755	0.0251	CbGeAlD
Glipizide—PPARG—female gonad—breast cancer	0.000728	0.0242	CbGeAlD
Glipizide—PPARG—endocrine gland—breast cancer	0.000677	0.0225	CbGeAlD
Glipizide—KCNJ11—lymph node—breast cancer	0.000666	0.0221	CbGeAlD
Glipizide—Glyburide—ABCC1—breast cancer	0.000486	0.132	CrCbGaD
Glipizide—CYP2C9—female reproductive system—breast cancer	0.000469	0.0156	CbGeAlD
Glipizide—PPARG—lymph node—breast cancer	0.000468	0.0155	CbGeAlD
Glipizide—CYP2C9—endocrine gland—breast cancer	0.000397	0.0132	CbGeAlD
Glipizide—CYP3A4—female reproductive system—breast cancer	0.000357	0.0119	CbGeAlD
Glipizide—Chlorpropamide—PTGS1—breast cancer	0.000325	0.0884	CrCbGaD
Glipizide—CYP3A4—endocrine gland—breast cancer	0.000302	0.01	CbGeAlD
Glipizide—Glyburide—ABCG2—breast cancer	0.000256	0.0698	CrCbGaD
Glipizide—Gliclazide—ALB—breast cancer	0.000213	0.0579	CrCbGaD
Glipizide—Chlorpropamide—ABCB1—breast cancer	0.000158	0.043	CrCbGaD
Glipizide—Glyburide—CYP3A4—breast cancer	0.000128	0.0349	CrCbGaD
Glipizide—Glyburide—ALB—breast cancer	0.000112	0.0304	CrCbGaD
Glipizide—Glyburide—ABCB1—breast cancer	0.000107	0.029	CrCbGaD
Glipizide—Pruritus—Fluorouracil—breast cancer	7.66e-05	0.000364	CcSEcCtD
Glipizide—Thrombocytopenia—Docetaxel—breast cancer	7.65e-05	0.000363	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—breast cancer	7.64e-05	0.000363	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—breast cancer	7.64e-05	0.000363	CcSEcCtD
Glipizide—Confusional state—Capecitabine—breast cancer	7.62e-05	0.000362	CcSEcCtD
Glipizide—Feeling abnormal—Paclitaxel—breast cancer	7.59e-05	0.000361	CcSEcCtD
Glipizide—Oedema—Capecitabine—breast cancer	7.56e-05	0.000359	CcSEcCtD
Glipizide—Gastrointestinal pain—Paclitaxel—breast cancer	7.53e-05	0.000358	CcSEcCtD
Glipizide—Diarrhoea—Gemcitabine—breast cancer	7.53e-05	0.000358	CcSEcCtD
Glipizide—Dizziness—Irinotecan—breast cancer	7.47e-05	0.000355	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—breast cancer	7.45e-05	0.000354	CcSEcCtD
Glipizide—Anorexia—Docetaxel—breast cancer	7.44e-05	0.000354	CcSEcCtD
Glipizide—Shock—Capecitabine—breast cancer	7.44e-05	0.000354	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—breast cancer	7.43e-05	0.000353	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—breast cancer	7.43e-05	0.000353	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—breast cancer	7.41e-05	0.000352	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—breast cancer	7.4e-05	0.000352	CcSEcCtD
Glipizide—Diarrhoea—Fluorouracil—breast cancer	7.4e-05	0.000352	CcSEcCtD
Glipizide—Thrombocytopenia—Capecitabine—breast cancer	7.4e-05	0.000352	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—breast cancer	7.38e-05	0.000351	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—breast cancer	7.36e-05	0.00035	CcSEcCtD
Glipizide—Sweating—Doxorubicin—breast cancer	7.33e-05	0.000348	CcSEcCtD
Glipizide—Urticaria—Paclitaxel—breast cancer	7.32e-05	0.000348	CcSEcCtD
Glipizide—Hyperhidrosis—Capecitabine—breast cancer	7.31e-05	0.000347	CcSEcCtD
Glipizide—Abdominal pain—Paclitaxel—breast cancer	7.28e-05	0.000346	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—breast cancer	7.23e-05	0.000344	CcSEcCtD
Glipizide—Anorexia—Capecitabine—breast cancer	7.21e-05	0.000343	CcSEcCtD
Glipizide—Vomiting—Mitoxantrone—breast cancer	7.18e-05	0.000341	CcSEcCtD
Glipizide—Vomiting—Irinotecan—breast cancer	7.18e-05	0.000341	CcSEcCtD
Glipizide—Dizziness—Fluorouracil—breast cancer	7.16e-05	0.00034	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—breast cancer	7.15e-05	0.00034	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—breast cancer	7.13e-05	0.000339	CcSEcCtD
Glipizide—Rash—Irinotecan—breast cancer	7.12e-05	0.000339	CcSEcCtD
Glipizide—Rash—Mitoxantrone—breast cancer	7.12e-05	0.000339	CcSEcCtD
Glipizide—Dermatitis—Mitoxantrone—breast cancer	7.12e-05	0.000338	CcSEcCtD
Glipizide—Dermatitis—Irinotecan—breast cancer	7.12e-05	0.000338	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Docetaxel—breast cancer	7.12e-05	0.000338	CcSEcCtD
Glipizide—Chills—Methotrexate—breast cancer	7.11e-05	0.000338	CcSEcCtD
Glipizide—Headache—Mitoxantrone—breast cancer	7.08e-05	0.000336	CcSEcCtD
Glipizide—Headache—Irinotecan—breast cancer	7.08e-05	0.000336	CcSEcCtD
Glipizide—Insomnia—Docetaxel—breast cancer	7.06e-05	0.000336	CcSEcCtD
Glipizide—Paraesthesia—Docetaxel—breast cancer	7.01e-05	0.000333	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—breast cancer	7e-05	0.000333	CcSEcCtD
Glipizide—Dyspnoea—Docetaxel—breast cancer	6.96e-05	0.000331	CcSEcCtD
Glipizide—Somnolence—Docetaxel—breast cancer	6.94e-05	0.00033	CcSEcCtD
Glipizide—Rash—Gemcitabine—breast cancer	6.94e-05	0.00033	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—breast cancer	6.93e-05	0.000329	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—breast cancer	6.93e-05	0.000329	CcSEcCtD
Glipizide—Erythema—Methotrexate—breast cancer	6.9e-05	0.000328	CcSEcCtD
Glipizide—Headache—Gemcitabine—breast cancer	6.89e-05	0.000328	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Capecitabine—breast cancer	6.89e-05	0.000327	CcSEcCtD
Glipizide—Flushing—Epirubicin—breast cancer	6.88e-05	0.000327	CcSEcCtD
Glipizide—Vomiting—Fluorouracil—breast cancer	6.88e-05	0.000327	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—breast cancer	6.88e-05	0.000327	CcSEcCtD
Glipizide—Dyspepsia—Docetaxel—breast cancer	6.87e-05	0.000327	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—breast cancer	6.86e-05	0.000326	CcSEcCtD
Glipizide—Insomnia—Capecitabine—breast cancer	6.84e-05	0.000325	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—breast cancer	6.83e-05	0.000324	CcSEcCtD
Glipizide—Rash—Fluorouracil—breast cancer	6.82e-05	0.000324	CcSEcCtD
Glipizide—Dermatitis—Fluorouracil—breast cancer	6.82e-05	0.000324	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—breast cancer	6.81e-05	0.000324	CcSEcCtD
Glipizide—Paraesthesia—Capecitabine—breast cancer	6.79e-05	0.000323	CcSEcCtD
Glipizide—Decreased appetite—Docetaxel—breast cancer	6.79e-05	0.000323	CcSEcCtD
Glipizide—Hypersensitivity—Paclitaxel—breast cancer	6.79e-05	0.000323	CcSEcCtD
Glipizide—Headache—Fluorouracil—breast cancer	6.78e-05	0.000322	CcSEcCtD
Glipizide—Gastrointestinal disorder—Docetaxel—breast cancer	6.74e-05	0.00032	CcSEcCtD
Glipizide—Dyspnoea—Capecitabine—breast cancer	6.74e-05	0.00032	CcSEcCtD
Glipizide—Nausea—Mitoxantrone—breast cancer	6.71e-05	0.000319	CcSEcCtD
Glipizide—Nausea—Irinotecan—breast cancer	6.71e-05	0.000319	CcSEcCtD
Glipizide—Constipation—Docetaxel—breast cancer	6.68e-05	0.000317	CcSEcCtD
Glipizide—Pain—Docetaxel—breast cancer	6.68e-05	0.000317	CcSEcCtD
Glipizide—Dyspepsia—Capecitabine—breast cancer	6.66e-05	0.000316	CcSEcCtD
Glipizide—Chills—Epirubicin—breast cancer	6.65e-05	0.000316	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—breast cancer	6.62e-05	0.000315	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—breast cancer	6.61e-05	0.000314	CcSEcCtD
Glipizide—Asthenia—Paclitaxel—breast cancer	6.61e-05	0.000314	CcSEcCtD
Glipizide—Decreased appetite—Capecitabine—breast cancer	6.57e-05	0.000312	CcSEcCtD
Glipizide—Nausea—Gemcitabine—breast cancer	6.54e-05	0.000311	CcSEcCtD
Glipizide—Gastrointestinal disorder—Capecitabine—breast cancer	6.53e-05	0.00031	CcSEcCtD
Glipizide—Pruritus—Paclitaxel—breast cancer	6.52e-05	0.00031	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—breast cancer	6.5e-05	0.000309	CcSEcCtD
Glipizide—Pain—Capecitabine—breast cancer	6.47e-05	0.000307	CcSEcCtD
Glipizide—Constipation—Capecitabine—breast cancer	6.47e-05	0.000307	CcSEcCtD
Glipizide—Erythema—Epirubicin—breast cancer	6.45e-05	0.000307	CcSEcCtD
Glipizide—Feeling abnormal—Docetaxel—breast cancer	6.44e-05	0.000306	CcSEcCtD
Glipizide—Nausea—Fluorouracil—breast cancer	6.43e-05	0.000305	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—breast cancer	6.41e-05	0.000305	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—breast cancer	6.4e-05	0.000304	CcSEcCtD
Glipizide—Gastrointestinal pain—Docetaxel—breast cancer	6.39e-05	0.000304	CcSEcCtD
Glipizide—Flushing—Doxorubicin—breast cancer	6.37e-05	0.000303	CcSEcCtD
Glipizide—Flatulence—Epirubicin—breast cancer	6.36e-05	0.000302	CcSEcCtD
Glipizide—Tension—Epirubicin—breast cancer	6.33e-05	0.000301	CcSEcCtD
Glipizide—Diarrhoea—Paclitaxel—breast cancer	6.3e-05	0.0003	CcSEcCtD
Glipizide—Nervousness—Epirubicin—breast cancer	6.27e-05	0.000298	CcSEcCtD
Glipizide—Feeling abnormal—Capecitabine—breast cancer	6.23e-05	0.000296	CcSEcCtD
Glipizide—Malaise—Methotrexate—breast cancer	6.22e-05	0.000296	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—breast cancer	6.21e-05	0.000295	CcSEcCtD
Glipizide—Vertigo—Methotrexate—breast cancer	6.2e-05	0.000295	CcSEcCtD
Glipizide—Gastrointestinal pain—Capecitabine—breast cancer	6.18e-05	0.000294	CcSEcCtD
Glipizide—Abdominal pain—Docetaxel—breast cancer	6.17e-05	0.000293	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—breast cancer	6.17e-05	0.000293	CcSEcCtD
Glipizide—Chills—Doxorubicin—breast cancer	6.16e-05	0.000293	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—breast cancer	6.13e-05	0.000291	CcSEcCtD
Glipizide—Dizziness—Paclitaxel—breast cancer	6.09e-05	0.00029	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—breast cancer	6.08e-05	0.000289	CcSEcCtD
Glipizide—Urticaria—Capecitabine—breast cancer	6.01e-05	0.000286	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—breast cancer	5.99e-05	0.000285	CcSEcCtD
Glipizide—Abdominal pain—Capecitabine—breast cancer	5.98e-05	0.000284	CcSEcCtD
Glipizide—Erythema—Doxorubicin—breast cancer	5.97e-05	0.000284	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—breast cancer	5.88e-05	0.00028	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—breast cancer	5.87e-05	0.000279	CcSEcCtD
Glipizide—Myalgia—Methotrexate—breast cancer	5.87e-05	0.000279	CcSEcCtD
Glipizide—Tension—Doxorubicin—breast cancer	5.86e-05	0.000279	CcSEcCtD
Glipizide—Vomiting—Paclitaxel—breast cancer	5.86e-05	0.000278	CcSEcCtD
Glipizide—Malaise—Epirubicin—breast cancer	5.82e-05	0.000277	CcSEcCtD
Glipizide—Rash—Paclitaxel—breast cancer	5.81e-05	0.000276	CcSEcCtD
Glipizide—Dermatitis—Paclitaxel—breast cancer	5.8e-05	0.000276	CcSEcCtD
Glipizide—Discomfort—Methotrexate—breast cancer	5.8e-05	0.000276	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—breast cancer	5.8e-05	0.000276	CcSEcCtD
Glipizide—Vertigo—Epirubicin—breast cancer	5.8e-05	0.000276	CcSEcCtD
Glipizide—Syncope—Epirubicin—breast cancer	5.79e-05	0.000275	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—breast cancer	5.78e-05	0.000275	CcSEcCtD
Glipizide—Headache—Paclitaxel—breast cancer	5.77e-05	0.000274	CcSEcCtD
Glipizide—Hypersensitivity—Docetaxel—breast cancer	5.75e-05	0.000273	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—breast cancer	5.74e-05	0.000273	CcSEcCtD
Glipizide—Confusional state—Methotrexate—breast cancer	5.68e-05	0.00027	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—breast cancer	5.67e-05	0.00027	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—breast cancer	5.63e-05	0.000268	CcSEcCtD
Glipizide—Asthenia—Docetaxel—breast cancer	5.6e-05	0.000266	CcSEcCtD
Glipizide—Hypertension—Epirubicin—breast cancer	5.57e-05	0.000265	CcSEcCtD
Glipizide—Hypersensitivity—Capecitabine—breast cancer	5.57e-05	0.000265	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—breast cancer	5.54e-05	0.000263	CcSEcCtD
Glipizide—Pruritus—Docetaxel—breast cancer	5.53e-05	0.000263	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—breast cancer	5.51e-05	0.000262	CcSEcCtD
Glipizide—Myalgia—Epirubicin—breast cancer	5.49e-05	0.000261	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—breast cancer	5.49e-05	0.000261	CcSEcCtD
Glipizide—Anxiety—Epirubicin—breast cancer	5.48e-05	0.00026	CcSEcCtD
Glipizide—Nausea—Paclitaxel—breast cancer	5.47e-05	0.00026	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—breast cancer	5.44e-05	0.000259	CcSEcCtD
Glipizide—Discomfort—Epirubicin—breast cancer	5.43e-05	0.000258	CcSEcCtD
Glipizide—Asthenia—Capecitabine—breast cancer	5.42e-05	0.000258	CcSEcCtD
Glipizide—Malaise—Doxorubicin—breast cancer	5.39e-05	0.000256	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—breast cancer	5.37e-05	0.000255	CcSEcCtD
Glipizide—Anorexia—Methotrexate—breast cancer	5.37e-05	0.000255	CcSEcCtD
Glipizide—Syncope—Doxorubicin—breast cancer	5.36e-05	0.000255	CcSEcCtD
Glipizide—Pruritus—Capecitabine—breast cancer	5.35e-05	0.000254	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—breast cancer	5.35e-05	0.000254	CcSEcCtD
Glipizide—Diarrhoea—Docetaxel—breast cancer	5.34e-05	0.000254	CcSEcCtD
Glipizide—Confusional state—Epirubicin—breast cancer	5.31e-05	0.000252	CcSEcCtD
Glipizide—Oedema—Epirubicin—breast cancer	5.27e-05	0.00025	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—breast cancer	5.25e-05	0.000249	CcSEcCtD
Glipizide—Shock—Epirubicin—breast cancer	5.18e-05	0.000246	CcSEcCtD
Glipizide—Diarrhoea—Capecitabine—breast cancer	5.17e-05	0.000246	CcSEcCtD
Glipizide—Dizziness—Docetaxel—breast cancer	5.16e-05	0.000245	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—breast cancer	5.16e-05	0.000245	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—breast cancer	5.16e-05	0.000245	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—breast cancer	5.13e-05	0.000244	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—breast cancer	5.09e-05	0.000242	CcSEcCtD
Glipizide—Insomnia—Methotrexate—breast cancer	5.09e-05	0.000242	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—breast cancer	5.08e-05	0.000242	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—breast cancer	5.08e-05	0.000242	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—breast cancer	5.07e-05	0.000241	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—breast cancer	5.05e-05	0.00024	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—breast cancer	5.02e-05	0.000239	CcSEcCtD
Glipizide—Anorexia—Epirubicin—breast cancer	5.02e-05	0.000239	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—breast cancer	5.02e-05	0.000239	CcSEcCtD
Glipizide—Somnolence—Methotrexate—breast cancer	5e-05	0.000238	CcSEcCtD
Glipizide—Dizziness—Capecitabine—breast cancer	5e-05	0.000238	CcSEcCtD
Glipizide—Vomiting—Docetaxel—breast cancer	4.97e-05	0.000236	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—breast cancer	4.95e-05	0.000235	CcSEcCtD
Glipizide—Rash—Docetaxel—breast cancer	4.92e-05	0.000234	CcSEcCtD
Glipizide—Dermatitis—Docetaxel—breast cancer	4.92e-05	0.000234	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—breast cancer	4.91e-05	0.000234	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—breast cancer	4.89e-05	0.000233	CcSEcCtD
Glipizide—Headache—Docetaxel—breast cancer	4.89e-05	0.000233	CcSEcCtD
Glipizide—Oedema—Doxorubicin—breast cancer	4.87e-05	0.000232	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—breast cancer	4.86e-05	0.000231	CcSEcCtD
Glipizide—Pain—Methotrexate—breast cancer	4.81e-05	0.000229	CcSEcCtD
Glipizide—Vomiting—Capecitabine—breast cancer	4.81e-05	0.000229	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—breast cancer	4.8e-05	0.000228	CcSEcCtD
Glipizide—Shock—Doxorubicin—breast cancer	4.8e-05	0.000228	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—breast cancer	4.77e-05	0.000227	CcSEcCtD
Glipizide—Rash—Capecitabine—breast cancer	4.77e-05	0.000227	CcSEcCtD
Glipizide—Insomnia—Epirubicin—breast cancer	4.76e-05	0.000226	CcSEcCtD
Glipizide—Dermatitis—Capecitabine—breast cancer	4.76e-05	0.000226	CcSEcCtD
Glipizide—Headache—Capecitabine—breast cancer	4.74e-05	0.000225	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—breast cancer	4.73e-05	0.000225	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—breast cancer	4.71e-05	0.000224	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—breast cancer	4.7e-05	0.000223	CcSEcCtD
Glipizide—Somnolence—Epirubicin—breast cancer	4.68e-05	0.000223	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—breast cancer	4.65e-05	0.000221	CcSEcCtD
Glipizide—Nausea—Docetaxel—breast cancer	4.64e-05	0.00022	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—breast cancer	4.64e-05	0.00022	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—breast cancer	4.64e-05	0.00022	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—breast cancer	4.6e-05	0.000219	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—breast cancer	4.58e-05	0.000218	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—breast cancer	4.55e-05	0.000216	CcSEcCtD
Glipizide—Pain—Epirubicin—breast cancer	4.5e-05	0.000214	CcSEcCtD
Glipizide—Constipation—Epirubicin—breast cancer	4.5e-05	0.000214	CcSEcCtD
Glipizide—Nausea—Capecitabine—breast cancer	4.49e-05	0.000213	CcSEcCtD
Glipizide—Urticaria—Methotrexate—breast cancer	4.47e-05	0.000213	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—breast cancer	4.45e-05	0.000211	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.44e-05	0.000211	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—breast cancer	4.41e-05	0.00021	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—breast cancer	4.38e-05	0.000208	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—breast cancer	4.35e-05	0.000207	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—breast cancer	4.34e-05	0.000206	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—breast cancer	4.33e-05	0.000206	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—breast cancer	4.31e-05	0.000205	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—breast cancer	4.29e-05	0.000204	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—breast cancer	4.24e-05	0.000201	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—breast cancer	4.21e-05	0.0002	CcSEcCtD
Glipizide—Urticaria—Epirubicin—breast cancer	4.18e-05	0.000199	CcSEcCtD
Glipizide—Pain—Doxorubicin—breast cancer	4.17e-05	0.000198	CcSEcCtD
Glipizide—Constipation—Doxorubicin—breast cancer	4.17e-05	0.000198	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—breast cancer	4.16e-05	0.000198	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—breast cancer	4.15e-05	0.000197	CcSEcCtD
Glipizide—Asthenia—Methotrexate—breast cancer	4.04e-05	0.000192	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—breast cancer	4.02e-05	0.000191	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—breast cancer	3.99e-05	0.000189	CcSEcCtD
Glipizide—Pruritus—Methotrexate—breast cancer	3.98e-05	0.000189	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—breast cancer	3.88e-05	0.000184	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—breast cancer	3.87e-05	0.000184	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—breast cancer	3.85e-05	0.000183	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—breast cancer	3.85e-05	0.000183	CcSEcCtD
Glipizide—Asthenia—Epirubicin—breast cancer	3.78e-05	0.00018	CcSEcCtD
Glipizide—Pruritus—Epirubicin—breast cancer	3.73e-05	0.000177	CcSEcCtD
Glipizide—Dizziness—Methotrexate—breast cancer	3.72e-05	0.000177	CcSEcCtD
Glipizide—Diarrhoea—Epirubicin—breast cancer	3.6e-05	0.000171	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—breast cancer	3.59e-05	0.000171	CcSEcCtD
Glipizide—Vomiting—Methotrexate—breast cancer	3.58e-05	0.00017	CcSEcCtD
Glipizide—Rash—Methotrexate—breast cancer	3.55e-05	0.000169	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—breast cancer	3.55e-05	0.000169	CcSEcCtD
Glipizide—Headache—Methotrexate—breast cancer	3.53e-05	0.000168	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—breast cancer	3.5e-05	0.000166	CcSEcCtD
Glipizide—Dizziness—Epirubicin—breast cancer	3.48e-05	0.000166	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—breast cancer	3.45e-05	0.000164	CcSEcCtD
Glipizide—Vomiting—Epirubicin—breast cancer	3.35e-05	0.000159	CcSEcCtD
Glipizide—Nausea—Methotrexate—breast cancer	3.34e-05	0.000159	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—breast cancer	3.33e-05	0.000159	CcSEcCtD
Glipizide—Rash—Epirubicin—breast cancer	3.32e-05	0.000158	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—breast cancer	3.32e-05	0.000158	CcSEcCtD
Glipizide—Headache—Epirubicin—breast cancer	3.3e-05	0.000157	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—breast cancer	3.22e-05	0.000153	CcSEcCtD
Glipizide—Nausea—Epirubicin—breast cancer	3.13e-05	0.000149	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—breast cancer	3.1e-05	0.000147	CcSEcCtD
Glipizide—Rash—Doxorubicin—breast cancer	3.07e-05	0.000146	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—breast cancer	3.07e-05	0.000146	CcSEcCtD
Glipizide—Headache—Doxorubicin—breast cancer	3.05e-05	0.000145	CcSEcCtD
Glipizide—Nausea—Doxorubicin—breast cancer	2.9e-05	0.000138	CcSEcCtD
Glipizide—KCNJ11—Metabolism—MTHFR—breast cancer	1.6e-05	0.000145	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOA1—breast cancer	1.6e-05	0.000145	CbGpPWpGaD
Glipizide—PPARG—Metabolism—STK11—breast cancer	1.58e-05	0.000143	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP19A1—breast cancer	1.58e-05	0.000143	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.57e-05	0.000142	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APRT—breast cancer	1.55e-05	0.00014	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—breast cancer	1.54e-05	0.000139	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CAV1—breast cancer	1.53e-05	0.000138	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.52e-05	0.000138	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.52e-05	0.000137	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—breast cancer	1.5e-05	0.000135	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—breast cancer	1.48e-05	0.000134	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.48e-05	0.000134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CAV1—breast cancer	1.48e-05	0.000134	CbGpPWpGaD
Glipizide—PPARG—Metabolism—COMT—breast cancer	1.47e-05	0.000133	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—breast cancer	1.46e-05	0.000132	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—breast cancer	1.46e-05	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ESRRA—breast cancer	1.46e-05	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ANGPTL4—breast cancer	1.46e-05	0.000132	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.45e-05	0.000131	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—breast cancer	1.44e-05	0.00013	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ITPR1—breast cancer	1.44e-05	0.00013	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—breast cancer	1.42e-05	0.000128	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—breast cancer	1.39e-05	0.000126	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.39e-05	0.000125	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HADHB—breast cancer	1.38e-05	0.000125	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPI—breast cancer	1.38e-05	0.000125	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—breast cancer	1.38e-05	0.000125	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—breast cancer	1.37e-05	0.000124	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TYMS—breast cancer	1.36e-05	0.000123	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—breast cancer	1.35e-05	0.000122	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NDUFS3—breast cancer	1.35e-05	0.000122	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—breast cancer	1.35e-05	0.000122	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—breast cancer	1.35e-05	0.000122	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOR1—breast cancer	1.34e-05	0.000121	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLA2G4A—breast cancer	1.34e-05	0.000121	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—breast cancer	1.34e-05	0.000121	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.32e-05	0.00012	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.32e-05	0.000119	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.32e-05	0.000119	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—breast cancer	1.31e-05	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.3e-05	0.000118	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GPX1—breast cancer	1.28e-05	0.000116	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—breast cancer	1.28e-05	0.000116	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—breast cancer	1.27e-05	0.000115	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A1—breast cancer	1.27e-05	0.000115	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CHST9—breast cancer	1.27e-05	0.000115	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NME1—breast cancer	1.27e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UMPS—breast cancer	1.27e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ADSL—breast cancer	1.27e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PHGDH—breast cancer	1.27e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FHL2—breast cancer	1.27e-05	0.000114	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ERCC2—breast cancer	1.26e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LDHB—breast cancer	1.24e-05	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BRIP1—breast cancer	1.24e-05	0.000112	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPSE—breast cancer	1.24e-05	0.000112	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—breast cancer	1.22e-05	0.00011	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—breast cancer	1.21e-05	0.000109	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COX11—breast cancer	1.2e-05	0.000109	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—breast cancer	1.19e-05	0.000107	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—breast cancer	1.18e-05	0.000107	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCC1—breast cancer	1.18e-05	0.000106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMMR—breast cancer	1.18e-05	0.000106	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA3—breast cancer	1.18e-05	0.000106	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—breast cancer	1.17e-05	0.000106	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—breast cancer	1.15e-05	0.000104	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.14e-05	0.000103	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—breast cancer	1.12e-05	0.000101	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—breast cancer	1.11e-05	0.000101	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.11e-05	0.0001	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.11e-05	0.0001	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CDA—breast cancer	1.1e-05	9.95e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SHMT1—breast cancer	1.1e-05	9.95e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CAV1—breast cancer	1.09e-05	9.88e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—breast cancer	1.08e-05	9.78e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA9—breast cancer	1.08e-05	9.72e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA4—breast cancer	1.08e-05	9.72e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—breast cancer	1.06e-05	9.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.06e-05	9.6e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A5—breast cancer	1.06e-05	9.58e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.06e-05	9.58e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—breast cancer	1.06e-05	9.53e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.05e-05	9.5e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX2—breast cancer	1.05e-05	9.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA2—breast cancer	1.05e-05	9.47e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.04e-05	9.44e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—breast cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SULT1A1—breast cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX4—breast cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—breast cancer	1.03e-05	9.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APRT—breast cancer	1.02e-05	9.25e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—breast cancer	1.02e-05	9.25e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—IDH1—breast cancer	1.01e-05	9.14e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTA1—breast cancer	1.01e-05	9.14e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NAT2—breast cancer	1e-05	9.04e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—breast cancer	9.96e-06	9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ESRRA—breast cancer	9.62e-06	8.7e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.62e-06	8.7e-05	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—breast cancer	9.55e-06	8.63e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—breast cancer	9.2e-06	8.31e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPI—breast cancer	9.12e-06	8.24e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HADHB—breast cancer	9.12e-06	8.24e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.04e-06	8.17e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—breast cancer	8.92e-06	8.06e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DPYD—breast cancer	8.77e-06	7.92e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MED12—breast cancer	8.77e-06	7.92e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—breast cancer	8.75e-06	7.91e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.7e-06	7.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.7e-06	7.86e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—breast cancer	8.64e-06	7.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDOA—breast cancer	8.63e-06	7.8e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA3—breast cancer	8.38e-06	7.57e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UMPS—breast cancer	8.34e-06	7.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FHL2—breast cancer	8.34e-06	7.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NME1—breast cancer	8.34e-06	7.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ADSL—breast cancer	8.34e-06	7.54e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PHGDH—breast cancer	8.34e-06	7.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A2—breast cancer	8.32e-06	7.52e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—breast cancer	8.27e-06	7.47e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.23e-06	7.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDHB—breast cancer	8.18e-06	7.39e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPSE—breast cancer	8.18e-06	7.39e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BRIP1—breast cancer	8.18e-06	7.39e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG2—breast cancer	8.15e-06	7.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CPT1A—breast cancer	8.15e-06	7.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTR—breast cancer	8.15e-06	7.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HPGDS—breast cancer	7.99e-06	7.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HBA1—breast cancer	7.94e-06	7.18e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMMR—breast cancer	7.76e-06	7.01e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA3—breast cancer	7.76e-06	7.01e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCC1—breast cancer	7.76e-06	7.01e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—breast cancer	7.75e-06	7.01e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACHE—breast cancer	7.75e-06	7.01e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—breast cancer	7.63e-06	6.9e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—breast cancer	7.56e-06	6.83e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.51e-06	6.79e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP17A1—breast cancer	7.34e-06	6.63e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS1—breast cancer	7.27e-06	6.57e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO1—breast cancer	7.27e-06	6.57e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—breast cancer	7.25e-06	6.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.24e-06	6.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.15e-06	6.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP2D6—breast cancer	7.13e-06	6.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA4—breast cancer	7.09e-06	6.41e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA9—breast cancer	7.09e-06	6.41e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—breast cancer	7.05e-06	6.37e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA2—breast cancer	6.99e-06	6.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA2—breast cancer	6.91e-06	6.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX2—breast cancer	6.91e-06	6.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX4—breast cancer	6.83e-06	6.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SULT1A1—breast cancer	6.83e-06	6.17e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FASN—breast cancer	6.78e-06	6.13e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BCHE—breast cancer	6.75e-06	6.1e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A5—breast cancer	6.67e-06	6.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTA1—breast cancer	6.67e-06	6.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—IDH1—breast cancer	6.67e-06	6.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NAT2—breast cancer	6.6e-06	5.96e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—breast cancer	6.59e-06	5.96e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—breast cancer	6.49e-06	5.87e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NQO1—breast cancer	6.44e-06	5.82e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A1—breast cancer	6.44e-06	5.82e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.31e-06	5.7e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—breast cancer	6.29e-06	5.69e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP3A4—breast cancer	6.28e-06	5.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.25e-06	5.65e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1B1—breast cancer	6.18e-06	5.58e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.06e-06	5.48e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA1—breast cancer	5.89e-06	5.33e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—STK11—breast cancer	5.81e-06	5.25e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP19A1—breast cancer	5.81e-06	5.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DPYD—breast cancer	5.78e-06	5.23e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MED12—breast cancer	5.78e-06	5.23e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDOA—breast cancer	5.69e-06	5.14e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA3—breast cancer	5.53e-06	4.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A2—breast cancer	5.49e-06	4.96e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.45e-06	4.93e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—COMT—breast cancer	5.4e-06	4.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG2—breast cancer	5.38e-06	4.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CPT1A—breast cancer	5.38e-06	4.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTR—breast cancer	5.38e-06	4.86e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—breast cancer	5.37e-06	4.86e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—breast cancer	5.3e-06	4.79e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—breast cancer	5.3e-06	4.79e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ITPR1—breast cancer	5.29e-06	4.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HPGDS—breast cancer	5.27e-06	4.76e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HBA1—breast cancer	5.24e-06	4.73e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—breast cancer	5.14e-06	4.65e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—breast cancer	5.11e-06	4.62e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACHE—breast cancer	5.11e-06	4.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—breast cancer	5.09e-06	4.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TYMS—breast cancer	5e-06	4.52e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOR1—breast cancer	4.94e-06	4.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—breast cancer	4.94e-06	4.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.94e-06	4.46e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AKT1—breast cancer	4.89e-06	4.42e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP17A1—breast cancer	4.84e-06	4.37e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO1—breast cancer	4.79e-06	4.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS1—breast cancer	4.79e-06	4.33e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPX1—breast cancer	4.73e-06	4.27e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP2D6—breast cancer	4.7e-06	4.25e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A1—breast cancer	4.68e-06	4.23e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—breast cancer	4.65e-06	4.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ERCC2—breast cancer	4.64e-06	4.2e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA2—breast cancer	4.61e-06	4.17e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FASN—breast cancer	4.47e-06	4.04e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BCHE—breast cancer	4.45e-06	4.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A5—breast cancer	4.4e-06	3.98e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—breast cancer	4.36e-06	3.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A1—breast cancer	4.25e-06	3.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NQO1—breast cancer	4.25e-06	3.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1B1—breast cancer	4.07e-06	3.68e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CAV1—breast cancer	4.03e-06	3.64e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSP90AA1—breast cancer	4e-06	3.61e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA1—breast cancer	3.89e-06	3.51e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.85e-06	3.48e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—STK11—breast cancer	3.83e-06	3.46e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP19A1—breast cancer	3.83e-06	3.46e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—breast cancer	3.8e-06	3.43e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CG—breast cancer	3.67e-06	3.31e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—COMT—breast cancer	3.56e-06	3.22e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—breast cancer	3.54e-06	3.2e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—breast cancer	3.5e-06	3.16e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ITPR1—breast cancer	3.49e-06	3.15e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—breast cancer	3.36e-06	3.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TYMS—breast cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.26e-06	2.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—breast cancer	3.26e-06	2.94e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOR1—breast cancer	3.26e-06	2.94e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—breast cancer	3.22e-06	2.91e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—breast cancer	3.18e-06	2.88e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPX1—breast cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A1—breast cancer	3.09e-06	2.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ERCC2—breast cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—breast cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—breast cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—breast cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—breast cancer	2.78e-06	2.52e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CAV1—breast cancer	2.66e-06	2.4e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—breast cancer	2.43e-06	2.19e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—breast cancer	2.42e-06	2.19e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—breast cancer	2.13e-06	1.92e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—breast cancer	2.1e-06	1.9e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—breast cancer	2.01e-06	1.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.85e-06	1.67e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—breast cancer	1.84e-06	1.66e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—breast cancer	1.71e-06	1.55e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—breast cancer	1.6e-06	1.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—breast cancer	1.4e-06	1.26e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—breast cancer	9.23e-07	8.34e-06	CbGpPWpGaD
